Back
Natera 10K Form
Buy
56
NTRA
Natera
Last Price:
85.42
Seasonality Move:
34.07%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NTRA News And Ratings
See the #1 stock for the next 7 days that we like better than NTRA
NTRA Financial Statistics
Sales & Book Value
| Annual Sales: | $1.08B |
|---|---|
| Cash Flow: | $-67.66M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $6.40 |
| Price / Book: | 13.76 |
Profitability
| EPS (TTM): | -3.79000 |
|---|---|
| Net Income (TTM): | $-434.8M |
| Gross Margin: | $492.74M |
| Return on Equity: | -62.07% |
| Return on Assets: | -31.74% |
Natera Earnings Forecast
Key Natera Financial Ratios
- The Gross Profit Margin over the past 11 years for NTRA is 45.52%.
- The Selling, General & Administrative Expenses for NTRA have been equal to 57.11% of Gross Profit Margin.
- The Research & Development expenses have been 29.62% of Revenue.
- The Interest Expense is -2.91% of Operating Income.
- The Net Earning history of NTRA is -40.16% of Total Revenues.
- Per Share Earnings over the last 11 years have been positive in 5 years.
Natera Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | NTRA |
| CUSIP: | 632307 |
| Website: | natera.com |
Debt
| Debt-to-Equity Ratio: | 0.47 |
|---|---|
| Current Ratio: | 4.1 |
| Quick Ratio: | 3.77 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |